ClinicalTrials.gg
Not yet recruitingNCT06077396radial arteryUpdated Nov 10, 2026

Does Radial Artery Cannulation Affect the Perfusion Index(PI) of the Hand in Liver Transplant Operations?

An interventional study of Conventional Palpation and Ultrasound-Guided Catheterization in Perfusion; Complications and Arterial Catheterization, Peripheral, sponsored by Inonu University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by Inonu University · Not applicable, Interventional, and Treatment

How we know

Updated Nov 10, 2026Start date movedPrimary completion moved+5 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This randomized controlled trial compared palpation-guided and ultrasound-guided radial artery catheterization in adult liver transplant recipients. The primary outcome was the change in perfusion index (Pi) from baseline after catheterization. Secondary outcomes included first-attempt success, number of skin punctures, procedure time, overall success with the assigned technique, and local complications.

Read the detailed description

## DLiver transplantation is associated with major hemodynamic changes, and continuous invasive arterial pressure monitoring is an essential part of perioperative management. The radial artery is the most commonly used site. Repeated punctures and mechanical trauma during catheterization may cause local complications and affect peripheral perfusion. Ultrasound guidance may facilitate catheter placement with fewer punctures.

The perfusion index (Pi), derived from pulse oximetry, is the ratio of the pulsatile to the non-pulsatile optical signal and is used to monitor peripheral perfusion. Because Pi is also influenced by systemic hemodynamics, sympathetic activity, temperature, nociception and drugs, changes in Pi were not interpreted as direct evidence of radial artery vasospasm.

In this prospective, randomized, controlled, two-arm parallel-group trial, adult liver transplant recipients were randomized 1:1 to palpation-guided or ultrasound-guided radial artery catheterization. Randomization used a computer-generated sequence and sequentially numbered, opaque, sealed envelopes prepared by an independent person. The envelope was opened after induction of general anesthesia, once hemodynamic stability was achieved and immediately before catheterization. All procedures were performed by a single anesthesiologist experienced in both techniques, using the same 20-gauge non-guidewire arterial cannula in both groups, preferably on the non-dominant hand after a normal modified Allen test.

In the ultrasound group, a high-frequency linear probe was used with a short-axis out-of-plane approach and dynamic needle tip positioning. Pi was measured continuously with a pulse oximetry sensor placed on the index finger the hand. Pi, heart rate, SpO2, pleth variability index (PVI), SpHb and SpOC were recorded immediately before catheterization (baseline) and immediately after catheterization; Pi was additionally recorded 5 and 10 minutes after catheterization.

The primary outcome was the change in Pi from baseline over time. The primary analysis used a linear mixed-effects model including group, time and the group-by-time interaction to account for repeated measurements. Secondary outcomes were compared with appropriate tests (t test or Mann-Whitney U test; chi-square or Fisher's exact test). Results were reported with effect estimates and 95% confidence intervals; a two-sided p\<0.05 was considered statistically significant.

02

Conditions studied

  • Perfusion; Complications
  • Arterial Catheterization, Peripheral

Keywords

  • perfusion index
  • liver transplantation
  • radial artery cannulation
03

In context

Lead sponsor

Inonu University is the lead sponsor of 399 studies on the registry; 98 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

The criteria were revised on the registry on Nov 10, 2026. See what changed

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients (18 years of age or older) undergoing liver transplantation.
  • Patients eligible for radial artery catheterization as part of perioperative monitoring.
  • Patients who provide to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • Patients in whom radial artery catheterization is .
  • Patients who do not provide to participate in the study.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
70 participants (estimated)

Study arms

  • Other
    Conventional Palpation

    Conventional Palpation

    Procedure: Conventional Palpation

  • Other
    Guided Catheterization

    -Radial artery catheterization was performed after induction of general anesthesia using the conventional palpation technique. The radial pulse was identified by palpation and the artery was cannulated using anatomical landmarks with a 20-gauge non-guidewire arterial cannula, limited to a maximum of three skin punctures.

    Procedure: Ultrasound-Guided Catheterization

Interventions

  • ProcedureConventional Palpation

    Radial artery catheterization was performed after induction of general anesthesia, preferably on the non-dominant hand after a normal modified Allen test. The radial pulse was identified by palpation and the artery was cannulated using anatomical landmarks with a 20-gauge non-guidewire arterial cannula, the same cannula used in the ultrasound group. The procedure was limited to a maximum of three skin punctures.

  • ProcedureUltrasound-Guided Catheterization

    Radial artery catheterization performed under real-time ultrasound guidance using an integrated guidewire arterial cannula system.

06

What researchers measure

Primary outcomes

  1. Change in Perfusion Index from Baseline Following Radial Artery Catheterization

    Perfusion index (Pi) will be measured at baseline, immediately after radial artery catheterization, and at 5 and 10 minutes after the procedure to assess changes in peripheral perfusion between the palpation-guided and ultrasound-guided catheterization groups.

    Time frame: Perfusion index (Pi) will be measured at baseline, immediately after radial artery catheterization, and at 5 and 10 minutes after the procedure to evaluate changes in peripheral perfusion.

Secondary outcomes

  1. First-Attempt Radial Artery Catheterization Success Rate

    The proportion of participants in whom radial artery catheterization is successfully completed on the first skin puncture.

    Time frame: During the catheterization procedure

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Brzezinski M, Luisetti T, London MJ. Radial artery cannulation: a comprehensive review of recent anatomic and physiologic investigations. Anesth Analg. 2009 Dec;109(6):1763-81. doi: 10.1213/ANE.0b013e3181bbd416. PubMed 19923502 ↗
  • Numaguchi A, Adachi YU, Aoki Y, Ishii Y, Suzuki K, Obata Y, Sato S, Nishiwaki K, Matsuda N. Radial artery cannulation decreases the distal arterial blood flow measured by power Doppler ultrasound. J Clin Monit Comput. 2015 Oct;29(5):653-7. doi: 10.1007/s10877-014-9648-5. Epub 2014 Dec 16. PubMed 25516161 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Start is estimated for Oct 2026; primary completion for Dec 2026, 1 month later.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 10, 2026: start Mar 2024 → Oct 2026, primary completion Jun 2024 → Dec 2026 and completion Jul 2024 → Dec 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 25, 2023
First posted
Oct 11, 2023
StartEst.
Oct 29, 2026was Mar 2024
Primary completionEst.
Dec 10, 2026was Jun 2024
CompletionEst.
Dec 10, 2026was Jul 2024
Last update
Nov 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Mar 1, 2024→Oct 29, 2026
Nov 10, 2026
Primary completion
Jun 1, 2024→Dec 10, 2026
Nov 10, 2026
Study completion
Jul 1, 2024→Dec 10, 2026
Nov 10, 2026
Enrollment
50→70
Nov 10, 2026
Eligibility
Maximum age 75 Years→none; Criteria largely rewritten (7 changes)
What changed in the criteria
Inclusion criteria
  • RemovedPatients undergoing liver transplantation Patients who will undergo intraarterial cannulation
  • AddedAdult patients (18 years of age or older) undergoing liver transplantation.
  • AddedPatients eligible for radial artery catheterization as part of perioperative monitoring.
  • AddedPatients who provide informed consent to participate in the study.
Exclusion criteria
  • RemovedPeripheral vascular diseases Prior upper extremity surgery Radial artery injury
  • AddedPatients in whom radial artery catheterization is contraindicated.
  • AddedPatients who do not provide informed consent to participate in the study.
Nov 10, 2026
Interventions
Added Procedure: Conventional Palpation·Procedure: Ultrasound-Guided Catheterization; removed Procedure: radial artery cannulation. Arms added: Conventional Palpation·Guided Catheterization; arms removed: To evaluate the effect of radial artery cannulation on hand perfusion
Nov 10, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • ChangedBefore To evaluate the perfusion index of the hand in which artery cannulation was performed with Masimo.There is no result rangeNow Change in Perfusion Index from Baseline Following Radial Artery CatheterizationTime frame: Intraoperative (patients during surgery) → Perfusion index (Pi) will be measured at baseline, immediately after radial artery catheterization, and at 5 and 10 minutes after the procedure to evaluate changes in peripheral perfusion.
Nov 10, 2026
Secondary outcomes
1 added
What changed in the outcomes
  • AddedFirst-Attempt Radial Artery Catheterization Success RateTime frame: During the catheterization procedure
Nov 10, 2026
Show all 1 update
  1. Nov 10, 2026
    Start date Mar 1, 2024→Oct 29, 2026
    Primary completion Jun 1, 2024→Dec 10, 2026
    Study completion Jul 1, 2024→Dec 10, 2026
    Enrollment 50→70
    Eligibility Maximum age 75 Years→none; Criteria largely rewritten (7 changes)
    What changed in the criteria
    Inclusion criteria
    • RemovedPatients undergoing liver transplantation Patients who will undergo intraarterial cannulation
    • AddedAdult patients (18 years of age or older) undergoing liver transplantation.
    • AddedPatients eligible for radial artery catheterization as part of perioperative monitoring.
    • AddedPatients who provide informed consent to participate in the study.
    Exclusion criteria
    • RemovedPeripheral vascular diseases Prior upper extremity surgery Radial artery injury
    • AddedPatients in whom radial artery catheterization is contraindicated.
    • AddedPatients who do not provide informed consent to participate in the study.
    Primary outcomes 1 edited
    What changed in the outcomes
    • ChangedBefore To evaluate the perfusion index of the hand in which artery cannulation was performed with Masimo.There is no result rangeNow Change in Perfusion Index from Baseline Following Radial Artery CatheterizationTime frame: Intraoperative (patients during surgery) → Perfusion index (Pi) will be measured at baseline, immediately after radial artery catheterization, and at 5 and 10 minutes after the procedure to evaluate changes in peripheral perfusion.
    Secondary outcomes 1 added
    What changed in the outcomes
    • AddedFirst-Attempt Radial Artery Catheterization Success RateTime frame: During the catheterization procedure
    Interventions Added Procedure: Conventional Palpation·Procedure: Ultrasound-Guided Catheterization; removed Procedure: radial artery cannulation. Arms added: Conventional Palpation·Guided Catheterization; arms removed: To evaluate the effect of radial artery cannulation on hand perfusion
    + 4 other changes: identifiers, verification date, description and design details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06077396
Lead sponsor
Inonu University
Responsible party
DUYGU DEMİROZ (Principal Investigator, Inonu University) — Principal investigator
First posted
Oct 11, 2023
Start date
Oct 29, 2026 (estimated)
Primary completion
Dec 10, 2026 (estimated)
Completion
Dec 10, 2026 (estimated)
Last update
Nov 10, 2026

Study contacts

duygu demiroz
Contact
drduygudemiroz@hotmail.com
905319504421
duygu demiröz
principal investigator · INONU UNİVERSİTY

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion